FI20105572A0 - Muokattu beeta-laktamaasi ja siihen liittyvät menetelmät ja käytöt - Google Patents
Muokattu beeta-laktamaasi ja siihen liittyvät menetelmät ja käytötInfo
- Publication number
- FI20105572A0 FI20105572A0 FI20105572A FI20105572A FI20105572A0 FI 20105572 A0 FI20105572 A0 FI 20105572A0 FI 20105572 A FI20105572 A FI 20105572A FI 20105572 A FI20105572 A FI 20105572A FI 20105572 A0 FI20105572 A0 FI 20105572A0
- Authority
- FI
- Finland
- Prior art keywords
- lactamase
- methods
- modified beta
- uses related
- beta
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N9/86—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/02—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amides (3.5.2)
- C12Y305/02006—Beta-lactamase (3.5.2.6)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Hematology (AREA)
Priority Applications (27)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20105572A FI20105572A0 (fi) | 2010-05-24 | 2010-05-24 | Muokattu beeta-laktamaasi ja siihen liittyvät menetelmät ja käytöt |
KR1020127033615A KR101708703B1 (ko) | 2010-05-24 | 2011-05-17 | 변형된 베타-락타마아제 및 이와 관련된 방법 및 용도 |
AU2011257092A AU2011257092C1 (en) | 2010-05-24 | 2011-05-17 | Modified beta-lactamases and methods and uses related thereto |
CN201180035810.5A CN103038341B (zh) | 2010-05-24 | 2011-05-17 | 经修饰的β-内酰胺酶及其相关方法和应用 |
US13/699,434 US9034602B2 (en) | 2010-05-24 | 2011-05-17 | Modified beta-lactamases and methods and uses related thereto |
ES11786185.6T ES2588279T3 (es) | 2010-05-24 | 2011-05-17 | Beta-lactamasas modificadas y métodos y usos relacionados con las mismas |
PL11786185T PL2576776T3 (pl) | 2010-05-24 | 2011-05-17 | Modyfikowane beta-laktamazy oraz powiązane z nimi sposoby i zastosowania |
EP11786185.6A EP2576776B1 (fr) | 2010-05-24 | 2011-05-17 | Bêta-lactamases modifiées et procédés et utilisations associés |
HUE11786185A HUE030689T2 (en) | 2010-05-24 | 2011-05-17 | Modified beta-lactamases and related methods and applications |
BR112012030029-6A BR112012030029B1 (pt) | 2010-05-24 | 2011-05-17 | Beta-lactamases modificadas, métodos, polinucleotídeo e composições relacionadas |
JP2013511709A JP5827681B2 (ja) | 2010-05-24 | 2011-05-17 | 改変型β−ラクタマーゼ並びにそれに関する方法及び使用 |
DK11786185.6T DK2576776T3 (en) | 2010-05-24 | 2011-05-17 | MODIFIED betalactamases AND PRACTICES AND USES RELATED ARTICLES |
CA2800671A CA2800671C (fr) | 2010-05-24 | 2011-05-17 | Beta-lactamases modifiees et procedes et utilisations associes |
PCT/FI2011/050450 WO2011148041A1 (fr) | 2010-05-24 | 2011-05-17 | Bêta-lactamases modifiées et procédés et utilisations associés |
RU2012155420/10A RU2570551C2 (ru) | 2010-05-24 | 2011-05-17 | Бета-лактамаза, способ ее модификации, получения и применение |
ZA2012/08948A ZA201208948B (en) | 2010-05-24 | 2012-11-27 | Modified beta-lactamases and methods and uses related thereto |
HK13111298.1A HK1183905A1 (zh) | 2010-05-24 | 2013-10-04 | 經修飾的β-內酰胺酶及其相關方法和應用 |
US14/047,882 US8894994B2 (en) | 2010-05-24 | 2013-10-07 | Modified beta-lactamases and methods and uses related thereto |
US14/517,539 US9301995B2 (en) | 2010-05-24 | 2014-10-17 | Modified beta-lactamases and methods and uses related thereto |
US14/676,559 US9301996B2 (en) | 2010-05-24 | 2015-04-01 | Modified beta-lactamases and methods and uses related thereto |
US15/054,292 US9587234B2 (en) | 2010-05-24 | 2016-02-26 | Modified beta-lactamases and methods and uses related thereto |
US15/138,767 US9765320B2 (en) | 2010-05-24 | 2016-04-26 | Modified beta-lactamases and methods and uses related thereto |
US15/417,501 US10041056B2 (en) | 2010-05-24 | 2017-01-27 | Modified beta-lactamases and methods and uses related thereto |
US15/661,416 US10253306B2 (en) | 2010-05-24 | 2017-07-27 | Modified beta-lactamases and methods and uses related thereto |
US16/279,547 US11214787B2 (en) | 2010-05-24 | 2019-02-19 | Modified beta-lactamases and methods and uses related thereto |
US17/533,739 US20220090044A1 (en) | 2010-05-24 | 2021-11-23 | Modified beta-lactamases and methods and uses related thereto |
US18/315,122 US20230332128A1 (en) | 2010-05-24 | 2023-05-10 | Modified beta-lactamases and methods and uses related thereto |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20105572A FI20105572A0 (fi) | 2010-05-24 | 2010-05-24 | Muokattu beeta-laktamaasi ja siihen liittyvät menetelmät ja käytöt |
Publications (1)
Publication Number | Publication Date |
---|---|
FI20105572A0 true FI20105572A0 (fi) | 2010-05-24 |
Family
ID=42234353
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI20105572A FI20105572A0 (fi) | 2010-05-24 | 2010-05-24 | Muokattu beeta-laktamaasi ja siihen liittyvät menetelmät ja käytöt |
Country Status (17)
Country | Link |
---|---|
US (11) | US9034602B2 (fr) |
EP (1) | EP2576776B1 (fr) |
JP (1) | JP5827681B2 (fr) |
KR (1) | KR101708703B1 (fr) |
CN (1) | CN103038341B (fr) |
AU (1) | AU2011257092C1 (fr) |
BR (1) | BR112012030029B1 (fr) |
CA (1) | CA2800671C (fr) |
DK (1) | DK2576776T3 (fr) |
ES (1) | ES2588279T3 (fr) |
FI (1) | FI20105572A0 (fr) |
HK (1) | HK1183905A1 (fr) |
HU (1) | HUE030689T2 (fr) |
PL (1) | PL2576776T3 (fr) |
RU (1) | RU2570551C2 (fr) |
WO (1) | WO2011148041A1 (fr) |
ZA (1) | ZA201208948B (fr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8992422B2 (en) | 2006-03-23 | 2015-03-31 | Ethicon Endo-Surgery, Inc. | Robotically-controlled endoscopic accessory channel |
FI20105572A0 (fi) | 2010-05-24 | 2010-05-24 | Prevab R Lcc | Muokattu beeta-laktamaasi ja siihen liittyvät menetelmät ja käytöt |
JP6685925B2 (ja) * | 2014-04-17 | 2020-04-22 | シンセティック バイオロジクス,インコーポレイテッド | 治療用として改善された特性を有するβ−ラクタマーゼ |
WO2016033327A1 (fr) | 2014-08-28 | 2016-03-03 | Synthetic Biologics, Inc. | Production de bêta-lactamase à partir d'e-coli |
AU2015330937B2 (en) * | 2014-10-08 | 2021-07-15 | Theriva Biologics, Inc. | Beta-lactamase formulations and uses thereof |
FR3027307B1 (fr) * | 2014-10-16 | 2016-11-04 | Azurrx Sas | Molecule proteique hybride apte a inhiber au moins un antibiotique et composition pharmaceutique la comportant |
US9744221B2 (en) | 2014-12-23 | 2017-08-29 | Synthetic Biologics, Inc. | Method and compositions for inhibiting or preventing adverse effects of oral antibiotics |
EP3261662B1 (fr) | 2015-02-23 | 2021-07-21 | Synthetic Biologics Inc. | Carbapénémases à utiliser avec des antibiotiques pour la protection du microbiome intestinal |
AU2016229976B2 (en) | 2015-03-06 | 2021-11-11 | Theriva Biologics, Inc. | Safe and effective beta-lactamase dosing for microbiome protection |
ES2922009T3 (es) * | 2016-02-23 | 2022-09-06 | Da Volterra | Variantes de beta-lactamasa |
US11185555B2 (en) | 2016-04-11 | 2021-11-30 | Noah James Harrison | Method to kill pathogenic microbes in a patient |
CN109562147B (zh) * | 2016-06-28 | 2023-09-01 | 特里瓦生物制剂有限公司 | 保护微生物组免受口服抗生素 |
CN116270991A (zh) * | 2016-11-01 | 2023-06-23 | 合成生物制品有限公司 | 用于减弱抗生素抗性的方法和组合物 |
CN110157699B (zh) * | 2018-02-12 | 2021-07-23 | 中国科学院微生物研究所 | β-内酰胺酶及其编码基因以及它们的应用 |
AU2019317986A1 (en) | 2018-08-05 | 2021-02-11 | Da Volterra | Method for improving anticancer agent efficacy |
CA3106433A1 (fr) | 2018-08-05 | 2020-02-13 | Da Volterra | Compositions pour le traitement d'une maladie du greffon contre l'hote |
CN110777178A (zh) * | 2019-12-02 | 2020-02-11 | 河北慧林生物科技有限公司 | 固定化羧基酯水解酶在氯唑西林、双氯西林、氟氯西林及苯唑西林侧链合成中的应用 |
CN114075560A (zh) * | 2020-08-18 | 2022-02-22 | 杭州俊丰生物工程有限公司 | 一种β-内酰胺酶的稳定组合物 |
EP4148136A1 (fr) | 2021-09-08 | 2023-03-15 | Da Volterra | Cellule de levure modifiée pour l'administration d'enzymes d'inactivation d'antibiotique |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL89987C (fr) | 1954-05-29 | |||
US2941995A (en) | 1957-08-02 | 1960-06-21 | Beecham Res Lab | Recovery of solid 6-aminopenicillanic acid |
US2982696A (en) | 1959-05-01 | 1961-05-02 | Schenley Ind Inc | Ion-exchange procedures for the purification of penicillinase |
US3070511A (en) | 1960-02-10 | 1962-12-25 | Lepetit Spa | Process for preparing 6-aminopenicillanic acid |
US3150059A (en) | 1962-12-26 | 1964-09-22 | Lilly Co Eli | Penicillin deacylation via actinoplanaceae fermentation |
US3239394A (en) | 1964-06-15 | 1966-03-08 | Merck & Co Inc | Process for producing 7-amino-cephalosporanic acid |
US3499909A (en) | 1966-05-18 | 1970-03-10 | Koninklijke Gist Spiritus | Process for production of 6-aminopenicillanic acid |
US3488729A (en) | 1966-08-22 | 1970-01-06 | Lilly Co Eli | Cephalothin ester |
GB1241844A (en) | 1968-08-23 | 1971-08-04 | Beecham Group Ltd | Penicillins |
FI59265C (fi) | 1974-08-13 | 1981-07-10 | Beecham Group Ltd | Foerfarande foer framstaellning av 6-aminopenicillansyra |
GB1463513A (en) | 1974-08-13 | 1977-02-02 | Beecham Group Ltd | Enzymes |
GB2199582A (en) | 1987-01-07 | 1988-07-13 | Bayer Ag | Analogues of pancreatic secretory trypsin inhibitor |
FR2613624B1 (fr) | 1987-04-10 | 1990-11-23 | Roussy Inst Gustave | Composition pharmaceutique, administrable par voie orale, destinee a reduire les effets des b-lactamines |
CA2007083A1 (fr) | 1989-01-09 | 1990-07-09 | Nobuhiko Katunuma | Usage pharmaceutique du trypstatin |
CS275231B2 (en) | 1989-09-29 | 1992-02-19 | Ustav Makormolekularni Chemie | Medicine bottle |
FI920206A0 (fi) | 1992-01-17 | 1992-01-17 | Pekka Untamo Heino | Medicinsk anvaendning, medicinskt foerfarande och preparat. |
EP0837925A1 (fr) | 1995-07-07 | 1998-04-29 | Novo Nordisk A/S | Production de proteines a l'aide de bacillus incapable de sporuler |
EP1391502B1 (fr) | 2001-05-29 | 2012-04-25 | Kao Corporation | Micro-organismes hotes |
FI112666B (fi) | 2001-11-06 | 2003-12-31 | Ipsat Therapies Oy | Itiöimätön Bacillus subtilis, sen valmistus ja käyttö |
FR2843302B1 (fr) | 2002-08-09 | 2004-10-22 | Centre Nat Rech Scient | Forme galenique pour la delivrance colique de principes actifs |
US7323303B2 (en) * | 2003-03-31 | 2008-01-29 | Hong Kong Polytechnic University | Modified β-lactamases and uses thereof |
EP1564286A1 (fr) | 2004-02-11 | 2005-08-17 | Université de Liège | Protéines hybrides de la beta-lactamase classe A |
IL163821A0 (en) * | 2004-08-31 | 2005-12-18 | Ravgalai Ltd Rapax Consortium | Software for management of legal motions Methods and kits for the detection of biotoxic andantibiotic residues |
BRPI0610683B8 (pt) | 2005-05-18 | 2021-05-25 | Hopitaux Paris Assist Publique | aplicação colônica de absorventes |
FI119190B (fi) * | 2006-06-21 | 2008-08-29 | Ipsat Therapies Oy | Modifioitu beta-laktamaasi ja menetelmä sen valmistamiseksi |
FI119678B (fi) | 2006-11-28 | 2009-02-13 | Ipsat Therapies Oy | Beta-laktamaasin käyttö |
FI20105572A0 (fi) | 2010-05-24 | 2010-05-24 | Prevab R Lcc | Muokattu beeta-laktamaasi ja siihen liittyvät menetelmät ja käytöt |
-
2010
- 2010-05-24 FI FI20105572A patent/FI20105572A0/fi not_active Application Discontinuation
-
2011
- 2011-05-17 BR BR112012030029-6A patent/BR112012030029B1/pt active IP Right Grant
- 2011-05-17 CA CA2800671A patent/CA2800671C/fr active Active
- 2011-05-17 ES ES11786185.6T patent/ES2588279T3/es active Active
- 2011-05-17 EP EP11786185.6A patent/EP2576776B1/fr active Active
- 2011-05-17 AU AU2011257092A patent/AU2011257092C1/en active Active
- 2011-05-17 WO PCT/FI2011/050450 patent/WO2011148041A1/fr active Application Filing
- 2011-05-17 DK DK11786185.6T patent/DK2576776T3/en active
- 2011-05-17 JP JP2013511709A patent/JP5827681B2/ja active Active
- 2011-05-17 PL PL11786185T patent/PL2576776T3/pl unknown
- 2011-05-17 CN CN201180035810.5A patent/CN103038341B/zh active Active
- 2011-05-17 US US13/699,434 patent/US9034602B2/en active Active
- 2011-05-17 KR KR1020127033615A patent/KR101708703B1/ko active IP Right Grant
- 2011-05-17 RU RU2012155420/10A patent/RU2570551C2/ru not_active IP Right Cessation
- 2011-05-17 HU HUE11786185A patent/HUE030689T2/en unknown
-
2012
- 2012-11-27 ZA ZA2012/08948A patent/ZA201208948B/en unknown
-
2013
- 2013-10-04 HK HK13111298.1A patent/HK1183905A1/zh unknown
- 2013-10-07 US US14/047,882 patent/US8894994B2/en active Active
-
2014
- 2014-10-17 US US14/517,539 patent/US9301995B2/en active Active
-
2015
- 2015-04-01 US US14/676,559 patent/US9301996B2/en active Active
-
2016
- 2016-02-26 US US15/054,292 patent/US9587234B2/en active Active
- 2016-04-26 US US15/138,767 patent/US9765320B2/en active Active
-
2017
- 2017-01-27 US US15/417,501 patent/US10041056B2/en active Active
- 2017-07-27 US US15/661,416 patent/US10253306B2/en active Active
-
2019
- 2019-02-19 US US16/279,547 patent/US11214787B2/en active Active
-
2021
- 2021-11-23 US US17/533,739 patent/US20220090044A1/en active Pending
-
2023
- 2023-05-10 US US18/315,122 patent/US20230332128A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI20105572A0 (fi) | Muokattu beeta-laktamaasi ja siihen liittyvät menetelmät ja käytöt | |
BR112012017441A2 (pt) | compostos e métodos | |
FI20100223A0 (fi) | Menetelmä ja hissijärjestely | |
BR112014012137A2 (pt) | anticorpos anti-fgfr2 e suas utilizações | |
BR112013001592A2 (pt) | artigo e método | |
CO6990717A2 (es) | Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina | |
BR112013010847A2 (pt) | artigo e método | |
BR112012027159A2 (pt) | estrutura e método | |
DK2613884T3 (da) | Findelingsindretning | |
UA21863S (uk) | Гучномовець | |
CO6781486A2 (es) | Compuestos y su uso | |
BR112013016641A2 (pt) | artigo e método | |
DE112011102851A5 (de) | Drehsteller | |
DE11786796T8 (de) | Antigenpeptid und verwendung davon | |
BR112012021749A2 (pt) | processos e compostos | |
DK2571902T3 (da) | Ny fremgangsmåde | |
FI20115631A0 (fi) | Immunostimulatoriset yhdisteet ja niiden käyttö | |
FI20106369A0 (fi) | Kaiutinrakenne | |
FI20105760A (fi) | Menetelmä ja järjestely | |
BR112013013441A2 (pt) | composição de adesivo-engomadura e métodos relacionados | |
BR112013014731A2 (pt) | tamavidina modificada | |
FI20115880L (fi) | Suojamateriaali ja sen käyttö | |
BR112013018331A2 (pt) | diferencial | |
ES1071715Y (es) | Aposito | |
DE112011104090A5 (de) | Radfelgengetriebe und Planetenumlaufgetriebe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |